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The ATPase activity of Zajdela hepatoma and Yoshida sarcoma submitochondrial particles was several 
times lower than the enzyme activity in rat heart and rat liver submitochondrial particles. The content of 
F,-ATPase in the tumor mitochondria was found not to be very different from that in mitochondria of 
rat liver. Immunochemical determination of the amount of the natural ATPase inhibitor revealed that the 
tumor mitochondria contain 2-3-times more ATPase inhibitor than control mitochondria. It is concluded 
that the low ATPase activity of the tumor mitochondria results from the inhibition of the enzyme activity 
by the natural ATPase inhibitor. 
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1. INTRODUCTION 
Mitochondria of different tumors exhibit 
ATPase activity which could not be maximally 
activated under the conditions known to elicit the 
maximum ATPase activity of normal mitochon- 
dria. This could reflect (a) a defective ATPase 
molecule, (b) a lower content of the enzyme, or (c) 
an inhibition of the ATPase activity in tumor 
mitochondria. 
Fi-ATPase isolated from Zajdela hepatoma 
possesses the same enzymatic, electrophoretic and 
immunological properties as the enzyme from rat 
liver [l]. The content of Fi-ATPase in Zajdela 
hepatoma mitochondria does not differ signifi- 
cantly from that in mitochondria of rat liver [2]. 
Yet, the maximum ATPase activity of Zajdela 
hepatoma mitochondria or submitochondrial par- 
ticles is about the half of the enzyme activity of rat 
liver mitochondria or submitochondrial particles. 
A possible explanation of these observations is that 
the natural ATPase inhibitor in Zajdela hepatoma 
mitochondria is either more efficient or present in 
a larger amount compared with mitochondria of 
rat liver. 
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Here, we compared the contents of Fi-ATPase 
and the natural ATPase inhibitor in normal (rat 
liver and heart) and tumor (Zajdela hepatoma and 
Yoshida sarcoma) mitochondria using sensitive im- 
munochemical methods. The results show that the 
low ATPase activity of tumor mitochondria results 
from a higher content of natural ATPase inhibitor 
in these mitochondria. 
2. MATERIALS AND METHODS 
Ascitic Zajdela hepatoma and Yoshida sarcoma 
were maintained and mitochondria isolated as in 
[3]. Sonic submitochondrial particles were 
prepared according to [4] at pH 9.2. The particles 
were depleted of the ATPase inhibitor by gel filtra- 
tion [5] at alkaline pH. After elution from the col- 
umn with 0.25 M KCl, 75 mM sucrose, 2 mM 
EDTA, 30 mM Tris-HaSOd, pH 9.2, the particles 
were centrifuged and resuspended in 0.25 M 
sucrose, 10 mM Mops, pH 6.5. ATPase activity 
was determined in a coupled system [6]. ATPase 
inhibitor was isolated from beef heart according to 
[7]. Fi-ATPase was isolated [8] and further 
purified [9] from rat liver. Antisera against 
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Table I 
The effect of Sephadex treatment on ATPase activity of submitochondrial particles 
Source of submitochondrial 
particles 
Specific ATPase activity @mol PJmin per mg) 
Submitochondrial S-particles S-particles 
particles supplemented with 
ATPase inhibitor 
Rat heart 0.89 1.80 0.36 
Rat liver 0.64 1.08 0.60 
Zajdela hepatoma 0.38 1.30 0.32 
Yoshida sarcoma 0.18 0.64 0.15 
Submitochondrial and S-particles were prepared as described in section 2. For the reconstitution 
experiments with isolated ATPase inhibitor 250 pg S-particles were incubated with 6.25 ,ug ATPase 
inhibitor (25 pg ATPase inhibitor/mg S-particles) in 250 ~10.25 M sucrose, 10 mM Mops (pH 6.3, 
0.5 mM MgATP for 15 min at room temperature. 100 pg of particles were used for determining the 
ATPase activity 
ATPase inhibitor [lo] and Fr-ATPase [I 11 were liver, Zajdela hepatoma and Yoshida sarcoma 
raised in rabbits. Radioimmunoassay of the were: 2.4 : 1: 0.92 : 0.62. Approximately the same 
ATPase inhibitor was performed [l] using 1251- values also hold for the ratios of the Fi-ATPase 
iodinated [12] ATPase inhibitor as the labeled contents in submitochondrial particles from the ex- 
competing antigen. SDS-polyacrylamide gel elec- amined sources. It is highly unlikely that the 
trophoresis (SDS-PAGE) [ 131, immunoblotting observed small differences in the Fr-ATPase con- 
[14] and protein estimation [15] were performed tent could account for the observed variances in 
according to published procedures. the ATPase activities. 
3. RESULTS AND DISCUSSION 
Table 1 shows the ATPase activity of sub- 
mitochondrial particles from the examined 
sources. The ATPase activity of rat heart and rat 
liver submitochondrial particles was considerably 
higher than the enzyme activity of the particles 
from Zajdela hepatoma and Yoshida sarcoma. 
Determination of the ATPase activity in mitochon- 
dria disrupted sonically or by repeated freezing 
and thawing and in submitochondrial particles 
prepared using different sonication times indicated 
no preferential loss of the ATPase activity from 
the tumor membranes during sonication. The dif- 
ferent ATPase activities in the types of sub- 
mitochondrial particles .studied could thus result 
either from an unequal content of Fr-ATPase or 
from an unequal inhibition of the ATPase activity. 
The Fr-ATPase content in the examined types of 
mitochondria was compared by quantitative im- 
munoblotting (fig.1). The estimated ratios of the 
Fr-ATPase contents in mitochondria of rat heart, 
The possibility that the unequal ATPase activity 
of the preparations with similar Fr-ATPase con- 
tent reflects a different inhibition of the enzyme by 
the natural ATPase inhibitor was further exa- 
mined. The ATPase activities of submitochondrial 
particles devoid of the inhibitor (S-particles) were 
determined. The ATPase activity of submitochon- 
drial particles from rat heart and rat liver increased 
1.5-2-times, whereas that of the tumor particles 
increased 3-4-times upon removal of the inhibitor 
(table 1). The addition of an excess of the ATPase 
inhibitor to rat liver and tumor S-particles resulted 
in a decrease in the ATPase activity to values close 
to those found in the submitochondrial particles 
prior to the removal of the inhibitor. The ATPase 
activity of rat heart S-particles decreased below the 
activity of the original particles. This indicates a 
partial release of the ATPase inhibitor from rat 
heart mitochondria during preparation of sonic 
submitochondrial particles by the methods used. 
The above data strongly suggest that the low 
ATPase activity of tumor submitochondrial par- 
ticles is due to the inhibition of the enzyme activity 
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Fig.1. The content of Fr-ATPase in rat heart, rat liver, 
Zajdela hepatoma and Yoshida sarcoma mitochondria. 
Lanes 1-3, isolated Ft-ATPase, 0.25,0.5 and 1 ,ug; lanes 
4-6, rat heart; lanes 7-9, rat liver; lanes 10-12, Zajdela 
hepatoma; lanes 13-15, Yoshida sarcoma. The amounts 
of mitochondrial protein used were 5, 7.5 and 10ag. 
Relative contents of Fr-ATPase in respective types of 
mitochondria were estimated by measuring the 
radioactivity. 
by the natural ATPase inhibitor. Therefore, the 
amount of the ATPase inhibitor in the studied 
types of mitochondria was compared using com- 
petition radioimmunoassay. The reliability of the 
assay was confirmed by determining the content of 
the inhibitor in beef heart mitochondria, which in 
accordance with the published data [ 161 was found 
to be in the 1: 1 stoichiometry with Fr-ATPase. 
Since the antiserum against beef heart ATPase in- 
hibitor and the labeled competing antigen from the 
same source were used in the assay, the absolute 
amounts of the inhibitor in rat mitochondria could 
not be evaluated. However, as all of the compared 
types of mitochondria were of rat origin it is 
reasonable to assume that the antiserum used was 
equally cross-reactive with all of them, and that the 
relative values for respective rat mitochondria are 
valid. The relative contents of the ATPase in- 
hibitor in submitochondrial particles of rat heart, 
liver, Zajdela hepatoma and Yoshida sarcoma 
were 4: 1: 1.9: 4 whereas in whole mitochondria 
they were 18.5: 1:2.2: 3 (table 2, fig.2). The 
decrease in the relative amount of the inhibitor in 
rat heart mitochondria upon the conversion to sub- 
mitochondrial particles is in accord with the con- 
clusion drawn from the reconstitution experiment 
with S-particles and isolated ATPase inhibitor. 
The differences in the content of ATPase inhibitor 
in submitochondrial particles from the sources ex- 
amined practically disappear after the conversion 
of submitochondrial particles to S-particles. 
Our data show that the low ATPase activity of 
at least the tumor mitochondria examined results 
Table 2 
Relative content of the ATPase inhibitor in 
submitochondrial particles prior and after the Sephadex 
treatment 
Source of 
mitochondria 
Relative content of ATPase 
inhibitor in: 
or particles 
Mito- Submito- S- 
chondria chondrial particles 
particles 
Rat heart 18.5 4 1.12 
Rat liver 1 1 1 
Zajdela hepatoma 1.9 2.2 1.3 
Yoshida sarcoma 3 4 1.2 
The amount of ATPase inhibitor was detected using 
competition radioimmunoassay [l] 
Fig.2. Detection of ATPase inhibitor in mitochondria 
from rat heart, rat liver, Zajdela hepatoma and Yoshida 
sarcoma by competition radioimmunoassay. (H) 
Isolated ATPase inhibitor, (W) rat heart, (M) 
rat liver, (n--o) Zajdela hepatoma, (a) Yoshida 
sarcoma mitochondria. 
from the inhibition of the ATPase activity by the 
natural ATPase inhibitor. Moreover, they suggest 
that the inhibition is due to the elevated mitochon- 
drial content of the inhibitor rather than to a more 
efficient inhibition of the ATPase activity in the 
tumor mitochondria. Recently, it has been shown 
that in Zajdela hepatoma mitochondria the 
respiratory chain components are greatly enriched, 
whereas the content of Fr-ATPase is not increased 
compared to mitochondria of rat liver [2]. It ap- 
pears that in these mitochondria the content of the 
ATPase inhibitor follows the tendency of other in- 
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ner membrane components to increase rather than 
to remain in a constant stoichiometry with the 
ATPase complex. 
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